Ameluz FDA Approval History
Last updated by Judith Stewart, BPharm on March 2, 2021.
FDA Approved: Yes (First approved May 10, 2016)
Brand name: Ameluz
Generic name: aminolevulinic acid
Dosage form: Gel
Previous Name: BF-200 ALA
Company: Biofrontera AG
Treatment for: Actinic Keratosis
Ameluz (aminolevulinic acid) is a porphyrin precursor used in combination with the BF-RhodoLED lamp for photodynamic therapy (PDT) treatment of actinic keratoses on the face and scalp.
Development timeline for Ameluz
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
